Le SIDA au Ghana (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Prevalence and Impact of Hepatitis B and C Virus Co-Infections in Antiretroviral Treatment Naive Patients With HIV Infection at a Major Treatment Center in Ghana

Identifieur interne : 000789 ( Main/Exploration ); précédent : 000788; suivant : 000790

Prevalence and Impact of Hepatitis B and C Virus Co-Infections in Antiretroviral Treatment Naive Patients With HIV Infection at a Major Treatment Center in Ghana

Auteurs : Kwamena William Coleman Sagoe [Ghana] ; Afrakoma Adjoa Agyei [Ghana] ; Francesca Ziga [Ghana] ; Margaret Lartey [Ghana] ; Theophilus K. Adiku [Ghana] ; Makafui Seshi Max Q. Arens [États-Unis] ; Julius Abraham Addo Mingle [Ghana]

Source :

RBID : Pascal:12-0195630

Descripteurs français

English descriptors

Abstract

Data on the effects of the presence of hepatitis B virus (HBV) and hepatitis C virus (HCV) in patients co-infected with these viruses and HIV in West Africa are conflicting and little information is available in Ghana. A cohort of 138 treatment naïve individuals infected with HIV was screened for HBV and HCV serologic markers; HBsAg positive patients were tested for HBeAg, anti-HBe, and anti-HBc IgM. The viral load of HIV-1 in the plasma was determined in 81 patients. Eighteen of the 138 patients (13%) and 5 (3.6%) had HBsAg and anti-HCV, respectively. None of the patients had anti-HBc IgM, but 10 (55.6%) and 8 (44.4%) of the 18 patients who were HBsAg positive had HBeAg and anti-HBe, respectively. In patients with measurement of CD4+ undertaken within 1 month (n = 83), CD4+ count was significantly lower in patients with HBeAg (median [IQR], 81 [22-144]) as compared to those with anti-HBe (median [IQR], 210 [197-222]) (P= 0.002, CI: -96.46 to 51.21). However, those with HIV mono-infection had similar CD4+ counts (median [IQR], 57 [14-159]) compared to those with HBeAg (P= 1.0, CI: -71.75 to 73.66). Similar results were obtained if CD4+ count was measured within 2 months prior to initiation of HAART (n = 119). Generally, HBV and anti-HCV did not affect CD4+ and viral loads of HIV-1 in plasma but patients with HIV and HBV co-infection who had HBeAg had more severe immune suppression as compared to those with anti-HBe. This may have implication for initiating HAART in HBV endemic areas.


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en" level="a">Prevalence and Impact of Hepatitis B and C Virus Co-Infections in Antiretroviral Treatment Naive Patients With HIV Infection at a Major Treatment Center in Ghana</title>
<author>
<name sortKey="Coleman Sagoe, Kwamena William" sort="Coleman Sagoe, Kwamena William" uniqKey="Coleman Sagoe K" first="Kwamena William" last="Coleman Sagoe">Kwamena William Coleman Sagoe</name>
<affiliation wicri:level="3">
<inist:fA14 i1="01">
<s1>Clinical Virology Laboratory, Department of Microbiology, University of Ghana Medical School</s1>
<s2>Accra</s2>
<s3>GHA</s3>
<sZ>1 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Ghana</country>
<placeName>
<settlement type="city">Accra</settlement>
<region nuts="2">Région du Grand Accra</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Adjoa Agyei, Afrakoma" sort="Adjoa Agyei, Afrakoma" uniqKey="Adjoa Agyei A" first="Afrakoma" last="Adjoa Agyei">Afrakoma Adjoa Agyei</name>
<affiliation wicri:level="3">
<inist:fA14 i1="02">
<s1>Department of Medicine, University of Ghana Medical School</s1>
<s2>Accra</s2>
<s3>GHA</s3>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Ghana</country>
<placeName>
<settlement type="city">Accra</settlement>
<region nuts="2">Région du Grand Accra</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Ziga, Francesca" sort="Ziga, Francesca" uniqKey="Ziga F" first="Francesca" last="Ziga">Francesca Ziga</name>
<affiliation wicri:level="3">
<inist:fA14 i1="03">
<s1>Pharmacy Department, Korle-Bu Teaching Hospital</s1>
<s2>Accra</s2>
<s3>GHA</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Ghana</country>
<placeName>
<settlement type="city">Accra</settlement>
<region nuts="2">Région du Grand Accra</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Lartey, Margaret" sort="Lartey, Margaret" uniqKey="Lartey M" first="Margaret" last="Lartey">Margaret Lartey</name>
<affiliation wicri:level="3">
<inist:fA14 i1="02">
<s1>Department of Medicine, University of Ghana Medical School</s1>
<s2>Accra</s2>
<s3>GHA</s3>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Ghana</country>
<placeName>
<settlement type="city">Accra</settlement>
<region nuts="2">Région du Grand Accra</region>
</placeName>
<placeName>
<settlement type="city">Accra</settlement>
<settlement type="town">Legon (Ghana)</settlement>
<region type="region">Région du Grand Accra</region>
</placeName>
<orgName type="university" n="3">Université du Ghana</orgName>
</affiliation>
</author>
<author>
<name sortKey="Adiku, Theophilus K" sort="Adiku, Theophilus K" uniqKey="Adiku T" first="Theophilus K." last="Adiku">Theophilus K. Adiku</name>
<affiliation wicri:level="3">
<inist:fA14 i1="01">
<s1>Clinical Virology Laboratory, Department of Microbiology, University of Ghana Medical School</s1>
<s2>Accra</s2>
<s3>GHA</s3>
<sZ>1 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Ghana</country>
<placeName>
<settlement type="city">Accra</settlement>
<region nuts="2">Région du Grand Accra</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Arens, Makafui Seshi Max Q" sort="Arens, Makafui Seshi Max Q" uniqKey="Arens M" first="Makafui Seshi Max Q." last="Arens">Makafui Seshi Max Q. Arens</name>
<affiliation wicri:level="2">
<inist:fA14 i1="04">
<s1>Retrovirus Laboratory, Department of Pediatrics, Washington University Medical School</s1>
<s2>St. Louis, Missouri</s2>
<s3>USA</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName>
<region type="state">Missouri (État)</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Addo Mingle, Julius Abraham" sort="Addo Mingle, Julius Abraham" uniqKey="Addo Mingle J" first="Julius Abraham" last="Addo Mingle">Julius Abraham Addo Mingle</name>
<affiliation wicri:level="3">
<inist:fA14 i1="01">
<s1>Clinical Virology Laboratory, Department of Microbiology, University of Ghana Medical School</s1>
<s2>Accra</s2>
<s3>GHA</s3>
<sZ>1 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Ghana</country>
<placeName>
<settlement type="city">Accra</settlement>
<region nuts="2">Région du Grand Accra</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">INIST</idno>
<idno type="inist">12-0195630</idno>
<date when="2012">2012</date>
<idno type="stanalyst">PASCAL 12-0195630 INIST</idno>
<idno type="RBID">Pascal:12-0195630</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000019</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000110</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">000015</idno>
<idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">000015</idno>
<idno type="wicri:doubleKey">0146-6615:2012:Coleman Sagoe K:prevalence:and:impact</idno>
<idno type="wicri:Area/Main/Merge">000790</idno>
<idno type="wicri:Area/Main/Curation">000789</idno>
<idno type="wicri:Area/Main/Exploration">000789</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a">Prevalence and Impact of Hepatitis B and C Virus Co-Infections in Antiretroviral Treatment Naive Patients With HIV Infection at a Major Treatment Center in Ghana</title>
<author>
<name sortKey="Coleman Sagoe, Kwamena William" sort="Coleman Sagoe, Kwamena William" uniqKey="Coleman Sagoe K" first="Kwamena William" last="Coleman Sagoe">Kwamena William Coleman Sagoe</name>
<affiliation wicri:level="3">
<inist:fA14 i1="01">
<s1>Clinical Virology Laboratory, Department of Microbiology, University of Ghana Medical School</s1>
<s2>Accra</s2>
<s3>GHA</s3>
<sZ>1 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Ghana</country>
<placeName>
<settlement type="city">Accra</settlement>
<region nuts="2">Région du Grand Accra</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Adjoa Agyei, Afrakoma" sort="Adjoa Agyei, Afrakoma" uniqKey="Adjoa Agyei A" first="Afrakoma" last="Adjoa Agyei">Afrakoma Adjoa Agyei</name>
<affiliation wicri:level="3">
<inist:fA14 i1="02">
<s1>Department of Medicine, University of Ghana Medical School</s1>
<s2>Accra</s2>
<s3>GHA</s3>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Ghana</country>
<placeName>
<settlement type="city">Accra</settlement>
<region nuts="2">Région du Grand Accra</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Ziga, Francesca" sort="Ziga, Francesca" uniqKey="Ziga F" first="Francesca" last="Ziga">Francesca Ziga</name>
<affiliation wicri:level="3">
<inist:fA14 i1="03">
<s1>Pharmacy Department, Korle-Bu Teaching Hospital</s1>
<s2>Accra</s2>
<s3>GHA</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Ghana</country>
<placeName>
<settlement type="city">Accra</settlement>
<region nuts="2">Région du Grand Accra</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Lartey, Margaret" sort="Lartey, Margaret" uniqKey="Lartey M" first="Margaret" last="Lartey">Margaret Lartey</name>
<affiliation wicri:level="3">
<inist:fA14 i1="02">
<s1>Department of Medicine, University of Ghana Medical School</s1>
<s2>Accra</s2>
<s3>GHA</s3>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Ghana</country>
<placeName>
<settlement type="city">Accra</settlement>
<region nuts="2">Région du Grand Accra</region>
</placeName>
<placeName>
<settlement type="city">Accra</settlement>
<settlement type="town">Legon (Ghana)</settlement>
<region type="region">Région du Grand Accra</region>
</placeName>
<orgName type="university" n="3">Université du Ghana</orgName>
</affiliation>
</author>
<author>
<name sortKey="Adiku, Theophilus K" sort="Adiku, Theophilus K" uniqKey="Adiku T" first="Theophilus K." last="Adiku">Theophilus K. Adiku</name>
<affiliation wicri:level="3">
<inist:fA14 i1="01">
<s1>Clinical Virology Laboratory, Department of Microbiology, University of Ghana Medical School</s1>
<s2>Accra</s2>
<s3>GHA</s3>
<sZ>1 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Ghana</country>
<placeName>
<settlement type="city">Accra</settlement>
<region nuts="2">Région du Grand Accra</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Arens, Makafui Seshi Max Q" sort="Arens, Makafui Seshi Max Q" uniqKey="Arens M" first="Makafui Seshi Max Q." last="Arens">Makafui Seshi Max Q. Arens</name>
<affiliation wicri:level="2">
<inist:fA14 i1="04">
<s1>Retrovirus Laboratory, Department of Pediatrics, Washington University Medical School</s1>
<s2>St. Louis, Missouri</s2>
<s3>USA</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName>
<region type="state">Missouri (État)</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Addo Mingle, Julius Abraham" sort="Addo Mingle, Julius Abraham" uniqKey="Addo Mingle J" first="Julius Abraham" last="Addo Mingle">Julius Abraham Addo Mingle</name>
<affiliation wicri:level="3">
<inist:fA14 i1="01">
<s1>Clinical Virology Laboratory, Department of Microbiology, University of Ghana Medical School</s1>
<s2>Accra</s2>
<s3>GHA</s3>
<sZ>1 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Ghana</country>
<placeName>
<settlement type="city">Accra</settlement>
<region nuts="2">Région du Grand Accra</region>
</placeName>
</affiliation>
</author>
</analytic>
<series>
<title level="j" type="main">Journal of medical virology</title>
<title level="j" type="abbreviated">J. med. virol.</title>
<idno type="ISSN">0146-6615</idno>
<imprint>
<date when="2012">2012</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<title level="j" type="main">Journal of medical virology</title>
<title level="j" type="abbreviated">J. med. virol.</title>
<idno type="ISSN">0146-6615</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>AIDS</term>
<term>Antiretroviral agent</term>
<term>Antiviral</term>
<term>Epidemiology</term>
<term>Hepatitis</term>
<term>Hepatitis B virus</term>
<term>Hepatitis C virus</term>
<term>Human immunodeficiency virus</term>
<term>Mixed infection</term>
<term>Prevalence</term>
<term>Treatment</term>
<term>Viral load</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Virus hépatite C</term>
<term>Virus hépatite B</term>
<term>Virus immunodéficience humaine</term>
<term>Prévalence</term>
<term>Epidémiologie</term>
<term>Antiviral</term>
<term>Antirétroviral</term>
<term>Traitement</term>
<term>Charge virale</term>
<term>Hépatite</term>
<term>Infection mixte</term>
<term>SIDA</term>
<term>Antigène CD4</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Data on the effects of the presence of hepatitis B virus (HBV) and hepatitis C virus (HCV) in patients co-infected with these viruses and HIV in West Africa are conflicting and little information is available in Ghana. A cohort of 138 treatment naïve individuals infected with HIV was screened for HBV and HCV serologic markers; HBsAg positive patients were tested for HBeAg, anti-HBe, and anti-HBc IgM. The viral load of HIV-1 in the plasma was determined in 81 patients. Eighteen of the 138 patients (13%) and 5 (3.6%) had HBsAg and anti-HCV, respectively. None of the patients had anti-HBc IgM, but 10 (55.6%) and 8 (44.4%) of the 18 patients who were HBsAg positive had HBeAg and anti-HBe, respectively. In patients with measurement of CD4
<sup>+</sup>
undertaken within 1 month (n = 83), CD4
<sup>+</sup>
count was significantly lower in patients with HBeAg (median [IQR], 81 [22-144]) as compared to those with anti-HBe (median [IQR], 210 [197-222]) (P= 0.002, CI: -96.46 to 51.21). However, those with HIV mono-infection had similar CD4
<sup>+</sup>
counts (median [IQR], 57 [14-159]) compared to those with HBeAg (P= 1.0, CI: -71.75 to 73.66). Similar results were obtained if CD4
<sup>+</sup>
count was measured within 2 months prior to initiation of HAART (n = 119). Generally, HBV and anti-HCV did not affect CD4
<sup>+</sup>
and viral loads of HIV-1 in plasma but patients with HIV and HBV co-infection who had HBeAg had more severe immune suppression as compared to those with anti-HBe. This may have implication for initiating HAART in HBV endemic areas.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Ghana</li>
<li>États-Unis</li>
</country>
<region>
<li>Missouri (État)</li>
<li>Région du Grand Accra</li>
</region>
<settlement>
<li>Accra</li>
<li>Legon (Ghana)</li>
</settlement>
<orgName>
<li>Université du Ghana</li>
</orgName>
</list>
<tree>
<country name="Ghana">
<region name="Région du Grand Accra">
<name sortKey="Coleman Sagoe, Kwamena William" sort="Coleman Sagoe, Kwamena William" uniqKey="Coleman Sagoe K" first="Kwamena William" last="Coleman Sagoe">Kwamena William Coleman Sagoe</name>
</region>
<name sortKey="Addo Mingle, Julius Abraham" sort="Addo Mingle, Julius Abraham" uniqKey="Addo Mingle J" first="Julius Abraham" last="Addo Mingle">Julius Abraham Addo Mingle</name>
<name sortKey="Adiku, Theophilus K" sort="Adiku, Theophilus K" uniqKey="Adiku T" first="Theophilus K." last="Adiku">Theophilus K. Adiku</name>
<name sortKey="Adjoa Agyei, Afrakoma" sort="Adjoa Agyei, Afrakoma" uniqKey="Adjoa Agyei A" first="Afrakoma" last="Adjoa Agyei">Afrakoma Adjoa Agyei</name>
<name sortKey="Lartey, Margaret" sort="Lartey, Margaret" uniqKey="Lartey M" first="Margaret" last="Lartey">Margaret Lartey</name>
<name sortKey="Ziga, Francesca" sort="Ziga, Francesca" uniqKey="Ziga F" first="Francesca" last="Ziga">Francesca Ziga</name>
</country>
<country name="États-Unis">
<region name="Missouri (État)">
<name sortKey="Arens, Makafui Seshi Max Q" sort="Arens, Makafui Seshi Max Q" uniqKey="Arens M" first="Makafui Seshi Max Q." last="Arens">Makafui Seshi Max Q. Arens</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/SidaGhanaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000789 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000789 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    SidaGhanaV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     Pascal:12-0195630
   |texte=   Prevalence and Impact of Hepatitis B and C Virus Co-Infections in Antiretroviral Treatment Naive Patients With HIV Infection at a Major Treatment Center in Ghana
}}

Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Tue Nov 7 18:07:38 2017. Site generation: Tue Mar 5 15:01:57 2024